These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28085697)

  • 41. Inhibition of Aurora A Kinase by Alisertib Induces Autophagy and Cell Cycle Arrest and Increases Chemosensitivity in Human Hepatocellular Carcinoma HepG2 Cells.
    Zhu Q; Yu X; Zhou ZW; Zhou C; Chen XW; Zhou SF
    Curr Cancer Drug Targets; 2017; 17(4):386-401. PubMed ID: 27396604
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [EEF1A2 inhibits the p53 function in hepatocellular carcinoma via PI3K/AKT/mTOR-dependent stabilization of MDM4].
    Longerich T
    Pathologe; 2014 Nov; 35 Suppl 2():177-84. PubMed ID: 25394965
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Active form of AKT controls cell proliferation and response to apoptosis in hepatocellular carcinoma.
    Kunter I; Erdal E; Nart D; Yilmaz F; Karademir S; Sagol O; Atabey N
    Oncol Rep; 2014 Feb; 31(2):573-80. PubMed ID: 24337632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dual PI3K/mTOR inhibitor NVP-BEZ235-induced apoptosis of hepatocellular carcinoma cell lines is enhanced by inhibitors of autophagy.
    Chang Z; Shi G; Jin J; Guo H; Guo X; Luo F; Song Y; Jia X
    Int J Mol Med; 2013 Jun; 31(6):1449-56. PubMed ID: 23588698
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization.
    Fei M; Lu M; Wang Y; Zhao Y; He S; Gao S; Ke Q; Liu Y; Li P; Cui X; Shen A; Cheng C
    Med Oncol; 2009; 26(2):178-85. PubMed ID: 18937079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AMPK-mediated up-regulation of mTORC2 and MCL-1 compromises the anti-cancer effects of aspirin.
    Gao M; Kong Q; Hua H; Yin Y; Wang J; Luo T; Jiang Y
    Oncotarget; 2016 Mar; 7(13):16349-61. PubMed ID: 26918349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma.
    Liu YL; Yang PM; Shun CT; Wu MS; Weng JR; Chen CC
    Autophagy; 2010 Nov; 6(8):1057-65. PubMed ID: 20962572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells.
    Samarin J; Laketa V; Malz M; Roessler S; Stein I; Horwitz E; Singer S; Dimou E; Cigliano A; Bissinger M; Falk CS; Chen X; Dooley S; Pikarsky E; Calvisi DF; Schultz C; Schirmacher P; Breuhahn K
    Hepatology; 2016 Mar; 63(3):813-26. PubMed ID: 26901106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Co-activation of AKT and c-Met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice.
    Hu J; Che L; Li L; Pilo MG; Cigliano A; Ribback S; Li X; Latte G; Mela M; Evert M; Dombrowski F; Zheng G; Chen X; Calvisi DF
    Sci Rep; 2016 Feb; 6():20484. PubMed ID: 26857837
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cells.
    Cuconati A; Mills C; Goddard C; Zhang X; Yu W; Guo H; Xu X; Block TM
    PLoS One; 2013; 8(1):e54595. PubMed ID: 23355882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatocellular carcinoma redirects to ketolysis for progression under nutrition deprivation stress.
    Huang D; Li T; Wang L; Zhang L; Yan R; Li K; Xing S; Wu G; Hu L; Jia W; Lin SC; Dang CV; Song L; Gao P; Zhang H
    Cell Res; 2016 Oct; 26(10):1112-1130. PubMed ID: 27644987
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AMPK and PKA interaction in the regulation of survival of liver cancer cells subjected to glucose starvation.
    Ferretti AC; Tonucci FM; Hidalgo F; Almada E; Larocca MC; Favre C
    Oncotarget; 2016 Apr; 7(14):17815-28. PubMed ID: 26894973
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AGC1-mediated Metabolic Reprogramming and Autophagy Sustain Survival of Hepatocellular Carcinoma Cells under Glutamine Deprivation.
    Liu Y; Miao Z; Yang Q
    Cell Biochem Biophys; 2024 Sep; 82(3):2037-2053. PubMed ID: 38789662
    [TBL] [Abstract][Full Text] [Related]  

  • 54. P300/CBP-associated factor (PCAF) inhibits the growth of hepatocellular carcinoma by promoting cell autophagy.
    Jia YL; Xu M; Dou CW; Liu ZK; Xue YM; Yao BW; Ding LL; Tu KS; Zheng X; Liu QG
    Cell Death Dis; 2016 Oct; 7(10):e2400. PubMed ID: 27711074
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Downregulation of CLDN6 inhibits cell proliferation, migration, and invasion via regulating EGFR/AKT/mTOR signalling pathway in hepatocellular carcinoma.
    Huang L; Zhao C; Sun K; Yang D; Yan L; Luo D; He J; Hu X; Wang R; Shen X; Xiao N; Zhong Z
    Cell Biochem Funct; 2020 Jul; 38(5):541-548. PubMed ID: 32056244
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
    Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL
    Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The anti-hepatocellular carcinoma cell activity by a novel mTOR kinase inhibitor CZ415.
    Zhang W; Chen B; Zhang Y; Li K; Hao K; Jiang L; Wang Y; Mou X; Xu X; Wang Z
    Biochem Biophys Res Commun; 2017 Jun; 487(3):494-499. PubMed ID: 28366631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Galectin-1-Induced Autophagy Facilitates Cisplatin Resistance of Hepatocellular Carcinoma.
    Su YC; Davuluri GV; Chen CH; Shiau DC; Chen CC; Chen CL; Lin YS; Chang CP
    PLoS One; 2016; 11(2):e0148408. PubMed ID: 26859293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells.
    Dong J; Zhai B; Sun W; Hu F; Cheng H; Xu J
    PLoS One; 2017; 12(9):e0185088. PubMed ID: 28934275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of Akt signaling in hepatoma cells induces apoptotic cell death independent of Akt activation status.
    Buontempo F; Ersahin T; Missiroli S; Senturk S; Etro D; Ozturk M; Capitani S; Cetin-Atalay R; Neri ML
    Invest New Drugs; 2011 Dec; 29(6):1303-13. PubMed ID: 20628892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.